HBV genotypes and antiviral therapy of hepatitis B

Journal Title: Актуальна інфектологія - Year 2019, Vol 7, Issue 4

Abstract

At least 600 thousand individuals infected with hepatitis B virus (HBV) die annually worldwide due to liver cirrhosis and hepatocellular carcinoma. To date, efficiency of antiviral therapy for HBV infection is limited, so the main goal of treatment is prevention of liver disease progression and not complete eradication of HBV. At the same time, special attention is paid not only to the study of new drugs, but also to the optimization of existing approaches and to the search for new strategies for treatment of chronic hepatitis B. In this regard, many scientific studies deal with the correlation between HBV genotypes, progression of chronic hepatitis B and response to antiviral therapy. There are 10 known HBV genotypes (A-J) that in different ways affect natural history of disease, response to antiviral therapy and development of drug resistance. An individualized approach to the treatment of HBV infection with determination of HBV genotype may allow to better predict liver disease progression and to optimize treatment strategies. This literature review summarizes results of scientific studies regarding the impact of HBV genotypes on response to antiviral therapy with pegylated interferon and nucleos(t)ide analogs.

Authors and Affiliations

I. A. Zaitsev, I. M. Novak, O. Ye. Zaitseva, V. T. Kiriienko

Keywords

Related Articles

Optimization of Pathogenetic Treatment of Secretory Diarrhea in Infants

The aim of the research was to access clinical efficacy of oral rehydration therapy using III generation solutions in the treatment of secretory diarrhea in infants. To achieve this aim, on the basis of infectious box un...

Dynamics of Clinical-Biochemical and Immunological Parameters in Patients with Acute Hepatitis B Accompanied by Chronic Alcohol Consumption in Hepatotoxic Doses

It is shown that in patients with acute hepatitis B with concomitant chronic alcohol consumption in hepatotoxic doses in acute period of the disease is characterized by low serum levels of interleukin-2 and high levels o...

Nature of the Defeat of the Digestive System in Patients with Drug-Resistant Tuberculosis Using 2nd Line Drugs

The prevalence and nature of the defeat of the digestive system, depending on the profile of resistance to antituberculosis drugs in patients with drug-resistant pulmonary tuberculosis in the Chernivtsi region, were esta...

Therapist’s Take on the Treatment of Acute Viral Rhinitis in Pregnant Women

The paper analyses the influence of acute respiratory infections on pregnancy course. Special attention is paid to the impact of endogenous intoxication syndrome and substantiation of a choice for a study of its presence...

State of Compensatory-Adaptive Mechanisms in Patients with Purulent Meningitis in Dynamics of the Disease

The article analyzes the clinical features of autonomic dysfunction and state of compensatory-adaptive mechanisms in patients with purulent meningitis in the dynamics of the disease. We found that in patients with purule...

Download PDF file
  • EP ID EP655627
  • DOI 10.22141/2312-413x.7.4.2019.178879
  • Views 85
  • Downloads 0

How To Cite

I. A. Zaitsev, I. M. Novak, O. Ye. Zaitseva, V. T. Kiriienko (2019). HBV genotypes and antiviral therapy of hepatitis B. Актуальна інфектологія, 7(4), 189-195. https://europub.co.uk/articles/-A-655627